MedTrace Logo

Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E Patients

NCT01597765 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-05-15

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of antioxidant cocktails on the alleviation of oxidative stress and iron overload in beta-thalassemia/Hb E patients.

Conditions

Interventions

DRUG

curcuminoids, N-acetylcysteine, deferiprone and vitamin E

receiving curcuminoids 500 mg/day, N-acetylcysteine 200 mg/day deferiprone 50 mg/kg/day and vitamin E 400 IU/day

DRUG

Curcuminoids and alpha-tocopherol

group 1: receiving curcuminoids 500 mg/day, N-acetylcysteine 200 mg/day and deferiprone 50 mg/kg/day group 2: receiving vitamin E 400 IU/day, N-acetylcysteine 200 mg/day and deferiprone 50 mg/kg/day

Sponsors & Collaborators

  • Chiang Mai University

    collaborator OTHER

  • Mahidol University

    lead OTHER

Principal Investigators

  • Ruchaneekorn Kalpravidh, Assoc. Prof. Dr. · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Thailand

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01597765 on ClinicalTrials.gov